Skip to main content
Top
Published in: Alzheimer's Research & Therapy 1/2017

Open Access 01-12-2017 | Research

Cost of diagnosing dementia in a German memory clinic

Authors: Bernhard Michalowsky, Steffen Flessa, Johannes Hertel, Olav Goetz, Wolfgang Hoffmann, Stefan Teipel, Ingo Kilimann

Published in: Alzheimer's Research & Therapy | Issue 1/2017

Login to get access

Abstract

Background

Little is known about diagnostic work-ups or the costs of diagnosing dementia in specialized care. Here, we analyzed the costs of diagnosing dementia according to specific dementia disorders.

Methods

A prospective descriptive design was used to analyze the cost of diagnosing dementia for 120 patients with suspected dementia at a German memory clinic. The duration of clinical consultations and use of technical procedures were recorded by the memory clinic staff. To detect cost drivers, a multiple linear regression model was used.

Results

Of patients with suspected dementia, 44% were diagnosed with dementia. The total cost per patient and diagnostic process amounted to 501 € across all patients and 659 € for patients who were diagnosed with dementia. The costs varied between 649 € for patients with Alzheimer’s disease, 662 € for patients with vascular or mixed dementia, and 705 € for patients with unspecific dementia. A final diagnosis of dementia was the only factor that was significantly associated with the diagnostic cost (b = 356, CI 182, CI+ 531, p = 0.001).

Conclusion

The high range of costs reflects differences in diagnostic demands depending on the etiology of dementia. This variation needs to be transferred into reimbursement. Further studies are needed to assess the influence of the type of cognitive impairment and of the setting on diagnostic costs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer Report 2014—Dementia and Risk Reduction, an analysis of protective and modifiable risk factors. London: Alzheimer’s Disease International (ADI); 2014. 9/1/2014. Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer Report 2014—Dementia and Risk Reduction, an analysis of protective and modifiable risk factors. London: Alzheimer’s Disease International (ADI); 2014. 9/1/2014.
3.
go back to reference Fendrich K, Hoffmann W. More than just aging societies: the demographic change has an impact on actual numbers of patients. J Public Health. 2007;15(5):345–51.CrossRef Fendrich K, Hoffmann W. More than just aging societies: the demographic change has an impact on actual numbers of patients. J Public Health. 2007;15(5):345–51.CrossRef
6.
go back to reference Wimo A, Jonsson L, Gustavsson A, McDaid D, Ersek K, Georges J, et al. The economic impact of dementia in Europe in 2008—cost estimates from the Eurocode project. Int J Geriatr Psychiatry. 2011;26(8):825–32.CrossRefPubMed Wimo A, Jonsson L, Gustavsson A, McDaid D, Ersek K, Georges J, et al. The economic impact of dementia in Europe in 2008—cost estimates from the Eurocode project. Int J Geriatr Psychiatry. 2011;26(8):825–32.CrossRefPubMed
8.
go back to reference British Medical Journal. Care management helps people live with dementia. BMJ. 2006;333(7579):1163. British Medical Journal. Care management helps people live with dementia. BMJ. 2006;333(7579):1163.
10.
go back to reference Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9.
11.
go back to reference Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurol. 2007;6(8):734–46.CrossRefPubMed Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurol. 2007;6(8):734–46.CrossRefPubMed
12.
go back to reference Teipel SJ, Drzezga A, Grothe MJ, Barthel H, Chetelat G, Schuff N, et al. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection. Lancet Neurol. 2015;14(10):1037–53.CrossRefPubMed Teipel SJ, Drzezga A, Grothe MJ, Barthel H, Chetelat G, Schuff N, et al. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection. Lancet Neurol. 2015;14(10):1037–53.CrossRefPubMed
14.
go back to reference Kessler J, Markowitsch HJ, Denzler P. Mini-Mental-Status-Test (MMST) [German Version]. Beltz Test GmbH: Göttingen; 1990. Kessler J, Markowitsch HJ, Denzler P. Mini-Mental-Status-Test (MMST) [German Version]. Beltz Test GmbH: Göttingen; 1990.
15.
go back to reference Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed
16.
go back to reference Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004;19(2):136–43.CrossRefPubMed Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004;19(2):136–43.CrossRefPubMed
17.
go back to reference Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS. Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc. 1989;37(8):730–4.CrossRefPubMed Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS. Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc. 1989;37(8):730–4.CrossRefPubMed
18.
go back to reference Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V.(DEGAM). DEGAM-Leitlinie Nr 12: Demenz. omikron publishing: Düsseldorf; 2008. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V.(DEGAM). DEGAM-Leitlinie Nr 12: Demenz. omikron publishing: Düsseldorf; 2008.
19.
go back to reference Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138(11):927–37.CrossRefPubMed Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138(11):927–37.CrossRefPubMed
20.
go back to reference Connolly A, Gaehl E, Martin H, Morris J, Purandare N. Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health. 2011;15(8):978–84.CrossRefPubMed Connolly A, Gaehl E, Martin H, Morris J, Purandare N. Underdiagnosis of dementia in primary care: variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment Health. 2011;15(8):978–84.CrossRefPubMed
21.
go back to reference Eichler T, Thyrian JR, Hertel J, Köhler L, Wucherer D, Dreier A, et al. Rates of formal diagnosis in people screened positive for dementia in primary care: results of the DelpHi-Trial. J Alzheimers Dis. 2014;42(2):451–8.PubMed Eichler T, Thyrian JR, Hertel J, Köhler L, Wucherer D, Dreier A, et al. Rates of formal diagnosis in people screened positive for dementia in primary care: results of the DelpHi-Trial. J Alzheimers Dis. 2014;42(2):451–8.PubMed
22.
go back to reference Eichler T, Thyrian J, Hoffmann W. Rates of formal diagnosis in people screened positive for dementia in primary care and the effect of screning on diagnosis rates: results of the Delphi-trial. Alzheimers Dement. 2014;P610–1. Eichler T, Thyrian J, Hoffmann W. Rates of formal diagnosis in people screened positive for dementia in primary care and the effect of screning on diagnosis rates: results of the Delphi-trial. Alzheimers Dement. 2014;P610–1.
23.
go back to reference Kaduszkiewicz H, Wiese B, Steinmann S, et al. Diagnosing and diagnosis coding of dementias in claims data from German statutory health insurance. Psychiatr Prax. 2014;41(6):319-23. Kaduszkiewicz H, Wiese B, Steinmann S, et al. Diagnosing and diagnosis coding of dementias in claims data from German statutory health insurance. Psychiatr Prax. 2014;41(6):319-23.
24.
go back to reference Wimo A, Religa D, Spångberg K, Edlund A-K, Winblad B, Eriksdotter M. Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry. 2013;28(10):1039–44.CrossRefPubMed Wimo A, Religa D, Spångberg K, Edlund A-K, Winblad B, Eriksdotter M. Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry. 2013;28(10):1039–44.CrossRefPubMed
25.
go back to reference Jedenius E, Wimo A, Strömqvist J, Jönsson L, Andreasen N. The cost of diagnosing dementia in a community setting. Int J Geriatr Psychiatry. 2010;25(5):476–82.CrossRefPubMed Jedenius E, Wimo A, Strömqvist J, Jönsson L, Andreasen N. The cost of diagnosing dementia in a community setting. Int J Geriatr Psychiatry. 2010;25(5):476–82.CrossRefPubMed
27.
go back to reference Fehrle M, Michl S, Alte D, Götz O, Fleßa S. Time studies in hospitals. Gesundh ökon Qual Manag. 2013;18(1):23–30. Fehrle M, Michl S, Alte D, Götz O, Fleßa S. Time studies in hospitals. Gesundh ökon Qual Manag. 2013;18(1):23–30.
34.
go back to reference van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219–42.CrossRefPubMed van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16(3):219–42.CrossRefPubMed
35.
go back to reference Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585–98.CrossRefPubMed Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585–98.CrossRefPubMed
36.
go back to reference StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2014. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2014.
37.
go back to reference Jedenius E, Wimo A, Stromqvist J, Andreasen N. A Swedish programme for dementia diagnostics in primary healthcare. Scand J Prim Health Care. 2008;26(4):235–40. PMCID: 3406641.CrossRefPubMedPubMedCentral Jedenius E, Wimo A, Stromqvist J, Andreasen N. A Swedish programme for dementia diagnostics in primary healthcare. Scand J Prim Health Care. 2008;26(4):235–40. PMCID: 3406641.CrossRefPubMedPubMedCentral
38.
go back to reference Lueke S, et al. Qualitätsmerkmale deutscher Memory-Kliniken: Eine Querschnittsuntersuchung. Nervenarzt. 2012;83(9):1178–89.CrossRefPubMed Lueke S, et al. Qualitätsmerkmale deutscher Memory-Kliniken: Eine Querschnittsuntersuchung. Nervenarzt. 2012;83(9):1178–89.CrossRefPubMed
39.
go back to reference Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, et al. Antidementia drug treatment in people screened positive for dementia in primary care. J Alzheimer's Dis. 2015;44(3):1015–21. Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, et al. Antidementia drug treatment in people screened positive for dementia in primary care. J Alzheimer's Dis. 2015;44(3):1015–21.
40.
go back to reference Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. J Alzheimers Dis. 2013;35(2):349–61.PubMed Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. J Alzheimers Dis. 2013;35(2):349–61.PubMed
42.
go back to reference Dubois B, et al. Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges. J Alzheimers Dis. 2016;49(3):617–31.CrossRefPubMed Dubois B, et al. Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges. J Alzheimers Dis. 2016;49(3):617–31.CrossRefPubMed
44.
go back to reference Reilly S, et al. Case management approaches to home support for people with dementia. Cochrane Database Syst Rev. 2015;1:CD008345.PubMed Reilly S, et al. Case management approaches to home support for people with dementia. Cochrane Database Syst Rev. 2015;1:CD008345.PubMed
45.
go back to reference Gitlin LN, et al. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry. 2010;18(6):510–9.CrossRefPubMedPubMedCentral Gitlin LN, et al. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry. 2010;18(6):510–9.CrossRefPubMedPubMedCentral
46.
go back to reference Teipel SJ, et al. Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2007;257(6):330–6.CrossRefPubMed Teipel SJ, et al. Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2007;257(6):330–6.CrossRefPubMed
Metadata
Title
Cost of diagnosing dementia in a German memory clinic
Authors
Bernhard Michalowsky
Steffen Flessa
Johannes Hertel
Olav Goetz
Wolfgang Hoffmann
Stefan Teipel
Ingo Kilimann
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Alzheimer's Research & Therapy / Issue 1/2017
Electronic ISSN: 1758-9193
DOI
https://doi.org/10.1186/s13195-017-0290-6

Other articles of this Issue 1/2017

Alzheimer's Research & Therapy 1/2017 Go to the issue